Broomfield, CO, United States of America

Amy Whittier


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Westminster, CO (US) (2010)
  • Broomfield, CO (US) (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Amy Whittier: Innovator in Thromboxane A2 Detection

Introduction

Amy Whittier is a notable inventor based in Broomfield, CO (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of thromboxane A2 metabolites. With a total of 3 patents to her name, her work has the potential to enhance the understanding of aspirin's anti-thrombotic effectiveness.

Latest Patents

One of her latest patents focuses on methods and kits for the detection of thromboxane A2 metabolites. This innovation provides methods, compositions, and kits for measuring the effectiveness of aspirin in preventing thrombotic events in subjects. The patent includes a novel assay designed to quickly and specifically measure TxA2 metabolite levels in urine, correlating these levels with the aspirin dose administered to a subject. The methods utilize a unique anti-TxA2 metabolite antibody, which enhances the accuracy of the measurements.

Career Highlights

Throughout her career, Amy Whittier has worked with reputable companies such as Corgenix Medical Corporation and Cayman Chemical Company Incorporated. Her experience in these organizations has contributed to her expertise in the field of medical diagnostics and innovation.

Collaborations

Amy has collaborated with notable professionals in her field, including F Jon Geske and Daniel Tew. These collaborations have likely enriched her research and development efforts, leading to her successful patent applications.

Conclusion

Amy Whittier's contributions to the detection of thromboxane A2 metabolites represent a significant advancement in medical diagnostics. Her innovative methods and collaborations highlight her commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…